Company Tellgen Corporation

Equities

300642

CNE100002P42

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
14.39 ^CNY	+0.21%		+11.03%	-18.47%

Apr. 22	Tellgen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Tranche Update on Tellgen Corporation's Equity Buyback Plan announced on February 6, 2024.	CI

Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.

Number of employees: 710

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnostic Reagents 92.2 %	534	74.5 %	500	92.2 %	-6.23%
In Vitro Diagnostic Instruments 7.0 %	178	24.9 %	38	7.0 %	-78.75%
Service 0.8 %	4	0.5 %	4	0.8 %	+17.29%
Other 0.0 %	0	0.0 %	0	0.0 %	-63.95%

CNY in Million	2022	Weight	2023	Weight	Delta
China 98.8 %	704	98.3 %	536	98.8 %	-23.83%
Abroad 1.2 %	12	1.7 %	6	1.2 %	-45.46%

Managers	Title	Age	Since
Jian Er Yao CEO	Chief Executive Officer	54	03-11-05
Xiao Qing Wang BRD	Director/Board Member	45	09-07-31
En Huan Yang BRD	Director/Board Member	42	09-03-31

Members of the board	Title	Age	Since
Jian Er Yao CEO	Chief Executive Officer	54	03-11-05
Zhang Fu Yu BRD	Director/Board Member	61	19-08-13
En Huan Yang BRD	Director/Board Member	42	09-03-31
Xiao Qing Wang BRD	Director/Board Member	45	09-07-31
Wei Yu BRD	Director/Board Member	71	20-12-08
Jia Xiang Zhao BRD	Director/Board Member	48	20-12-08
Xiao Feng Zhang CHM	Chairman	45	20-12-08
Hong Zhan BRD	Director/Board Member	56	20-12-08
Shao Xiong Chen BRD	Director/Board Member	63	Dec. 24

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	167,275,083	108,294,626 ( 64.74 %)	3,148,842 ( 1.882 %)	64.74 %

Name	Equities	%	Valuation
Zhang Fu Yu 8.740 %	12,035,800	8.740 %	23 M ¥
Zhong Ou Asset Management Co., Ltd 1.714 %	2,359,907	1.714 %	5 M ¥
TELLGEN CORPORATION 0.7531 %	1,037,040	0.7531 %	2 M ¥
China Southern Asset Management Co., Ltd. 0.6741 %	928,260	0.6741 %	2 M ¥
Maxwealth Fund Management Co., Ltd. 0.2768 %	381,220	0.2768 %	739 502 ¥
Gfund Management Co., Ltd. 0.1340 %	184,500	0.1340 %	357 899 ¥
Bosera Asset Management Co., Ltd. 0.1175 %	161,746	0.1175 %	313 760 ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 0.0994 %	136,880	0.0994 %	265 524 ¥
HSBC Jintrust Fund Management Co. Ltd. 0.0671 %	92,400	0.0671 %	179 240 ¥
China Asset Management Co., Ltd. 0.0322 %	44,300	0.0322 %	85 934 ¥

Name	Equities	%	Valuation
TELLGEN CORPORATION 0.75%	1,037,040	0.75%	2,011,681 $

Tellgen Corp.

Building 1, 115 Bibo Road Lane 572, Pilot Free Trade Zone

201203, Shanghai

+86 21 5027 3499

http://www.tellgen.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
TELLGEN CORPORATION	-18.47%	323M
BIOMÉRIEUX	-0.60%	12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.84B
DIASORIN S.P.A.	+1.82%	5.5B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.61B
LANTHEUS HOLDINGS, INC.	+7.32%	4.61B
10X GENOMICS, INC.	-47.68%	3.4B
ANDON HEALTH CO., LTD.	+6.42%	2.66B
VITROLIFE AB	-14.59%	2.08B
MYRIAD GENETICS, INC.	+2.25%	1.79B

Diagnostic & Testing Substances